Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 436, 485 (28 July 2005) | doi:10.1038/436485a; Published online 27 July 2005
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
The H.G. Thode Postdoctoral Fellowships
- McMaster Institute of Applied Radiation Sciences
- Hamilton, Ontario Canada
Head of Analytical R&D
- Syngene International Limited
- Bangalore 560 099 India
India India's drug tests
T. V. Padma1
Abstract
Drug companies are converging on India to conduct low-cost clinical trials. But is it ready to become the outsourcing centre for the world? T. V. Padma investigates.
The average cost of a clinical trial in the United States is US$180 million. The average cost in India is US$100 million.
To read this story in full you will need to login or make a payment (see right).
